Stay updated on LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FiOQPC7XCSNblFTvd5rBJmZvIM5U.uncropped.jpg&w=3840&q=75)
Latest updates to the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page
- CheckyesterdayChange DetectedDifference0.6%
- Check2 days agoChange DetectedDifference1%
- Check3 days agoChange DetectedDifference0.4%
- Check4 days agoChange DetectedThe study has expanded to include 14 locations, and the revision has been updated from v2.9.7 to v2.10.0.SummaryDifference2%
- Check5 days agoChange DetectedDifference1%
- Check7 days agoChange DetectedDifference1%
Stay in the know with updates to LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.